Document Type


Publication Date



Developmental screening is essential for identifying children at risk of neurodevelopmental delays. It is particularly useful when assessing neurodevelopment in preterm infants as they are at an increased risk for delay when compared to full-term infants. The American Academy of Pediatrics recommends the use of these tools to reduce the risk of missed detection by using physician judgment alone. Birth to Five: Watch Me Thrive! is a federal program that further emphasizes the importance of using developmental screening tools and provides a guide of research-based tools that have been approved in the United States. The Ages and Stages Questionnaire is one of these tools. The ASQ is implemented as questionnaires that assess five areas of neurodevelopment and can be completed by parents or caregivers. The purpose of this study is to evaluate the performance of the KARVI scale in the assessment of neurodevelopment in comparison to the ASQ. To evaluate this, the KARVI scale and ASQ-3 will be administered during well-child visits during the first year of life. The study aims to assess the effectiveness and ease of use of the KARVI scale in identifying children at risk for developmental delay when compared to the ASQ.

Academic Level

medical student

Mentor/PI Department


Available for download on Sunday, July 27, 2025